Current portfolio positioning
A diversified portfolio across companies and sponsors
Sponsors with the highest share in NBPE’s portfolio at end-August 2020 include the parent group of its investment manager Neuberger Berman (10.3%), as well as private equity giant KKR (10.5%), and THL (8.7%), which focuses on mid-market growth companies in its four core industries of consumer, financial services, healthcare and technology & business solutions (see Exhibit 5). The top five GPs cover 37% of NBPE’s portfolio.
Exhibit 5: NBPE’s portfolio split by sponsor
|
|
Source: NBPE data as at end-August 2020
|
North America is 77% of the portfolio, with combined TMT and healthcare exposure at 40%
We have examined NBPE’s portfolio sensitivities in the context of the current pandemic. Region-wise, the company’s particular focus is on North America (77% of the portfolio at end-August 2020), supplemented by Europe (19%) and Asia/Rest of World (4%). Its exposure to sectors that should prove more resilient to the ongoing crisis include IT (18%), healthcare (15%) and communications and media (7%, although some advertising businesses have been challenged by lockdowns). This is broadly in line with the market as illustrated by the MSCI ACWI Index (see Exhibits 6 and 7). At the same time, it has a somewhat higher weighting towards industrials (17% vs 9% for MSCI ACWI).
Having said that, NBPE emphasises that common investment themes among its top 30 exposures (apart from technology and healthcare) include sectors with low cyclicality and/or long-term secular growth trends (also including some industrial businesses). Examples of businesses outside of TMT and healthcare that NBPE considers to be more defensive are USI (an analytics/consulting/ brokerage company active in P&C insurance, employee benefit, personal risk and retirement), GFL (a waste management services company that completed its IPO this year) and Action (a non-food discount retailer). Plays on secular trends include MHS (a provider of turnkey material handling automation solutions), Autostore (storage automation solutions) and PetSmart/Chewy (the latter of which is an online pet supplies retailer).
Exhibit 6: Portfolio split by sector
|
Exhibit 7: MSCI ACWI Index split by sector
|
|
|
Source: NBPE data at end-August 2020
|
Source: MSCI, Edison Investment Research
|
Exhibit 6: Portfolio split by sector
|
|
Source: NBPE data at end-August 2020
|
Exhibit 7: MSCI ACWI Index split by sector
|
|
Source: MSCI, Edison Investment Research
|
High proportion of companies with covenant lite debt or low leverage
An additional potential mitigating factor is the high proportion of companies with covenant lite debt (67% of NBPE’s top 50 investments at end-August 2020). This is in line with the broader market trend as nearly 80% of outstanding US leverage loans at end-2019 were covenant lite. Loose covenants are beneficial for equity investors, because they constitute more flexible funding terms limiting the risk of a COVID-19-induced credit crunch and providing more room for restructuring efforts if necessary, while they can translate into lower debt recovery rates on default.
Out of NBPE’s 50 largest investments as at end-August 2020, 8% in terms of fair value was invested in companies with relatively low leverage defined as net debt to EBITDA not greater than 3.0x. Across a large sample of NBPE’s portfolio at end-June 2020 (77 equity investments representing 84% of the equity exposure), average leverage went up between end-March and end-June 2020 from 4.3x to 4.7x (of last 12 months (LTM) EBITDA), which could be partially explained by lower results in Q220 across portfolio due to the lockdown. This is below the average level for US buyout transactions at 6.6x EBITDA in 2019 (which is close to the 2007 pre-crisis peak of 6.5x, according to Bain Capital data).
Investment manager remains confident about the portfolio’s resilience to COVID-19
We note that 41% of NBPE’s top 50 holdings at end-August 2020 represents companies with an enterprise value (EV) in excess of US$3.0bn, while a further 31% have EVs between US$1.0bn and US$2.9bn. Overall, a single-digit percentage of the current portfolio value (mostly oil & gas, discretionary retail and other discretionary) is considered by the investment manager as potentially experiencing a medium to high impact from COVID-19 in the medium to long term. Based on our discussion with the investment manager, we also understand that at this stage the manager is not aware of significant liquidity issues across NBPE’s material holdings (although it is still possible that some additional equity injections throughout the portfolio may be required over time).
Income portfolio: 41% in NB programmes, 59% from external sponsors at present
NBPE’s income investments (US$125.5m at end-August) consist, among others, of credit portfolios managed within the NB Alternatives Credit Opportunities Program and NB Specialty Finance Program (c 41% of the total income investments’ fair value at end-August 2020). The former programme is focused on opportunistic purchases of loans and bonds in the secondary market (often at a discount to face value) coupled with primary credit investments to support growth and recovery in existing PE-backed companies. The NB Specialty Finance Program looks for consumer, small business and bridge loans in order to build short duration, income producing credit portfolios. NBPE also has a number of income investments with third-party sponsors (see Exhibit 8).
Exhibit 8: Summary of NBPE’s income investments
Investment |
Region |
Date of investment |
Lead sponsor |
Description |
Fair value (US$m) |
NB Alternatives Credit Opps |
Global |
Sep-19 |
NB |
Diversified credit portfolio |
43.5 |
Cotiviti* |
US |
Aug-18 |
Veritas Capital |
Healthcare analytics |
28.0 |
Drive Medical |
US |
Jan-17** |
CD&R |
Medical equipment distributor |
13.2 |
Schumacher |
US |
Oct-15 |
Onex |
Agricultural machinery and tools |
9.9 |
Carestream |
US |
Jun-17 |
CD&R |
Dental equipment |
9.4 |
NB Specialty Finance |
Global |
Oct-18 |
NB |
Small balance loan portfolio |
7.7 |
ProAmpac |
US |
Nov-16 |
Pritzker Private Capital |
Flexible packaging supplier |
6.0 |
OB Hospitalist Group |
US |
Aug-17 |
Gryphon Investors |
Obstetrics & gynaecology hospitals |
3.5 |
Blue Nile |
US |
Mar-17 |
Bain Capital |
Online jewellery retailer |
2.5 |
Other |
- |
- |
- |
- |
1.8*** |
Total |
- |
- |
- |
- |
110.7 |
Source: NBPE data at end-August 2020. Note: *Payment-in-kind (PIK) preferred equity. **First investment in January 2017 (valued at US$5.4m) and second investment in October 2019 (US$7.5m). ***Calculated based on total and sum of disclosed investments and may be subject to a rounding error.
Potential liquidity from selling down listed holdings subject to GP’s decision
Holdings in listed companies made up 9% of the company’s private equity portfolio at end-August 2020. These are mostly attributable to seven listed companies: GFL, SolarWinds, Vertiv, Ingersoll Rand, Avantor, Brightview and Chewy (although the latter is held through an unlisted company, PetSmart). We note that NBPE holds these listed stocks through co-investment special purpose vehicles and, similarly to unlisted equity, is dependent on the lead sponsor’s decision with respect to selling down the investment (which is accounted for on a pro rata basis for each investor including NBPE). Still, it is worth noting that except for GFL, Progenity and Vertiv (the most recent IPOs making up a significant part of the listed exposure at end-August 2020), most of the portfolio is no longer subject to any lock-ups. Vitru, a Brazilian digital education provider, is another company within NBPE’s portfolio which completed its listing recently (in September 2020).
Portfolio valuation: Reflecting the rebound from March turmoil
Fair values of NBPE’s direct PE co-investments are in principle in line with valuations from lead sponsors received on a quarterly basis. These are in turn estimated predominantly based on financial results reported for the last 12 months and market multiples of relevant listed peers. In some instances, GPs may apply a forward-looking approach, ie value the respective holdings based on forecast/budgeted earnings.
We note that while NB’s internal valuation committee may adjust the fair values estimated by sponsors, it only happens in exceptional circumstances. An example would be when there are two lead sponsors in a given investment and both provide NBPE with different valuations, in which case the company would normally apply the midpoint between these two. Based on our conversation with the investment manager, we understand that there are no material positions in NBPE’s current portfolio with in-house adjustments to fair value.
Due to the timing of receipt of company valuations from underlying sponsors, these are reflected in the company’s reported NAV with a lag of up to three months. For instance, NBPE’s June factsheet largely contained fair values as at end-March 2020. Its NAV has subsequently been adjusted in its H120 financial report to reflect the end-June valuations received from GPs, resulting in a 7.2% upward revision from the initial June factsheet. Similarily, its NAV at end-August 2020 currently reflects most private company valuations as at end-June 2020 (adjusted for subsequent foreign exchange movements). Shares in listed companies are updated based on the closing price as at the respective date and are thus not subject to any lag.
NBPE’s primary debt investments are generally carried at cost plus accrued interest, while secondary debt investments normally are marked to market (depending on the availability of market quotations). Having said that, in the latter case, if the investment manager believes that market yields moved substantially since the last security pricing, it may apply a DCF valuation (based on expected future cash flows and market rates). We discuss how NBPE’s valuation approach translates into the company’s NAV total return (TR) in the ‘Performance’ section below.